Akero surges after report on plans for potential sale

1 month ago 2

• Healthcare
• On the Move
• M&A

• Shares of Akero Therapeutics (NASDAQ:AKRO) climbed on Tuesday after StreetInsider reported that the San Francisco, California-based liver drug developer is reviewing a potential sale of the company in response to a takeover bid from a strategic buyer.
• Citing a source

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. Akero surges after report on plans for potential sale